Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PET Detection of CCR2 in Human Atherosclerosis — Stella

Home/Carotid Atherosclerosis/PET Detection of CCR2 in Human Atherosclerosis

View on ClinicalTrials.gov

Recruiting

Back to Carotid Atherosclerosis trials

PET Detection of CCR2 in Human Atherosclerosis

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Washington University CCIR, St Louis, Missouri

Key details

Phase

Early testing

Sponsor

Washington University School of Medicine

Enrollment target

~100 participants

Started

October 2020

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 89 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.